ArticleJournal of fluorescence2026
Label-Free Fluorescent Detection of T4 PNK Using a DNA Mimic Green Fluorescent Protein-Based Turn-On Biosensor.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A new label‑free turn‑on fluorescent biosensor is established for highly sensitive and specific detection of T4 polynucleotide kinase (T4 PNK) activity by integrating DNA mimic green fluorescent protein (DMGFP) with λ exonuclease (λ exo) cleavage for the first time. The sensing mechanism relies on T4 PNK‑catalyzed 5'‑phosphorylation of hairpin HP‑DNA1, which triggers sequential λ exo digestion and releases ssDNA1. The liberated ssDNA1 hybridizes with DNA2 to assemble the active DMGFP structure, yielding drastic fluorescence enhancement upon binding DFHBI‑1T. Under optimized conditions, the sensor exhibits a linear response from 0 to 0.5 U/mL with a low detection limit of 0.01 U/mL and outstanding specificity toward T4 PNK. It enables quantitative evaluation of concentration‑dependent inhibition by (NH₄)₂SO₄ and Na₂HPO₄, and accurately quantifies endogenous polynucleotide kinase phosphatase (PNKP) in HeLa cell lysates. Featuring label‑free operation, rapid response, and low background, this DMGFP‑based strategy provides a reliable and versatile platform for T4 PNK activity analysis, inhibitor screening, and clinical diagnosis, showing great potential in nucleic acid metabolism research and biomedical applications.
Indexed as
Identifiers
42209914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.